oxazoles has been researched along with Cardiometabolic Syndrome in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (63.64) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, JH; Hwang, HY; Jeon, YE; Kim, J; Kim, KH; Kwon, HJ; Lee, DJ; Lee, MS; Lim, H; Lim, YM; Pagire, H; Park, K | 1 |
| Andjelkovic, M; Fischer, A; Gastaldelli, A; Heise, T; Herz, M; Nosek, L; Stirban, AO | 1 |
| Bousquet, P; Gomes, F; Gonçalves-de-Albuquerque, CF; Lessa, MA; Machado, MV; Nascimento, AR; Tibiriçá, E; Vieira, AB | 1 |
| Bénardeau, A; Hansen, BC; Meyer, M; Mizrahi, J; Sebokova, E; Tigno, XT | 1 |
| Bogdański, P; Bryl, W; Cymerys, M; Kujawska-Łuczak, M; Miczke, A; Pupek-Musialik, D | 1 |
| Ernsberger, P; Koletsky, RJ; Velliquette, RA | 1 |
| Anichkov, DA; Schastnaya, OV; Shostak, NA | 1 |
| Ernsberger, P; Kossover, R; Previs, SF; Velliquette, RA | 1 |
| Sirotiaková, J; Widimský, J | 1 |
| Fiévet, C; Fruchart, JC; Staels, B | 1 |
1 review(s) available for oxazoles and Cardiometabolic Syndrome
| Article | Year |
|---|---|
PPARalpha and PPARgamma dual agonists for the treatment of type 2 diabetes and the metabolic syndrome.
Topics: Alkanesulfonates; Animals; Diabetes Mellitus, Type 2; Glycine; Humans; Metabolic Syndrome; Models, Biological; Oxazoles; Phenylpropionates; PPAR alpha; PPAR gamma | 2006 |
3 trial(s) available for oxazoles and Cardiometabolic Syndrome
| Article | Year |
|---|---|
Aleglitazar, a dual peroxisome proliferator-activated receptor-α/γ agonist, improves insulin sensitivity, glucose control and lipid levels in people with type 2 diabetes: findings from a randomized, double-blind trial.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Administration Schedule; Fasting; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin Resistance; Insulin-Secreting Cells; Lipid Metabolism; Metabolic Syndrome; Middle Aged; Oxazoles; PPAR alpha; PPAR gamma; Thiophenes; Treatment Outcome | 2016 |
[The effect of analysed hypotensive drugs on certain metabolic parameters].
Topics: Adult; Antihypertensive Agents; Diabetes Mellitus, Type 2; Felodipine; Female; Humans; Hyperlipidemias; Hypertension; Hyperuricemia; Indoles; Male; Metabolic Syndrome; Middle Aged; Oxazoles; Rilmenidine | 2003 |
Comparison of rilmenidine and lisinopril on ambulatory blood pressure and plasma lipid and glucose levels in hypertensive women with metabolic syndrome.
Topics: Adult; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Glucose; Blood Pressure Monitoring, Ambulatory; Female; Heart Rate; Hemodynamics; Humans; Hypertension; Lisinopril; Metabolic Syndrome; Middle Aged; Oxazoles; Prospective Studies; Rilmenidine; Single-Blind Method; Statistics, Nonparametric; Treatment Outcome | 2005 |
7 other study(ies) available for oxazoles and Cardiometabolic Syndrome
| Article | Year |
|---|---|
A novel autophagy enhancer as a therapeutic agent against metabolic syndrome and diabetes.
Topics: Animals; Autophagy; Diabetes Mellitus; HeLa Cells; Humans; Hypoglycemic Agents; Lipid Metabolism; Male; Metabolic Syndrome; Metabolome; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Obese; Obesity; Oxazoles; Stress, Physiological | 2018 |
Central Sympathetic Modulation Reverses Microvascular Alterations in a Rat Model of High-Fat Diet-Induced Metabolic Syndrome.
Topics: Adrenergic alpha-Agonists; Animals; Clonidine; Diet, High-Fat; Intravital Microscopy; Male; Metabolic Syndrome; Microcirculation; Microvessels; Muscle, Skeletal; Oxazoles; Rats; Rats, Wistar; Rilmenidine; Sodium Chloride, Dietary; Sympathetic Nervous System; Sympatholytics | 2016 |
Effects of aleglitazar, a balanced dual peroxisome proliferator-activated receptor α/γ agonist on glycemic and lipid parameters in a primate model of the metabolic syndrome.
Topics: Administration, Oral; Animals; Apolipoprotein A-I; Apolipoprotein A-II; Biomarkers; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Disease Models, Animal; Eating; Glycated Hemoglobin; Hypertriglyceridemia; Hypoglycemic Agents; Hypolipidemic Agents; Insulin Resistance; Macaca mulatta; Male; Metabolic Syndrome; Obesity; Oxazoles; PPAR alpha; PPAR gamma; Prediabetic State; Thiophenes; Time Factors; Triglycerides; Weight Loss | 2011 |
The role of I(1)-imidazoline receptors and alpha(2)-adrenergic receptors in the modulation of glucose and lipid metabolism in the SHROB model of metabolic syndrome X.
Topics: Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Benzofurans; Blood Pressure; Disease Models, Animal; Female; Glucagon; Glucose; Glucose Tolerance Test; Humans; Imidazoles; Imidazoline Receptors; Lipid Metabolism; Male; Metabolic Syndrome; Obesity; Oxazoles; Rats; Rats, Inbred SHR; Receptors, Adrenergic, alpha-2; Receptors, Drug; Rilmenidine; Yohimbine | 2003 |
Meeting highlights. 65th annual scientific sessions of the American Diabetes Association, San Diego. Dual PPAR agonist improves glycemic control, lipids in type 2 diabetes.
Topics: Diabetes Mellitus, Type 2; Glycine; Humans; Hypoglycemic Agents; Metabolic Syndrome; Oxazoles; Pioglitazone; Thiazolidinediones; United States | 2005 |
Lipid-lowering actions of imidazoline antihypertensive agents in metabolic syndrome X.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Cell Membrane; Cholesterol; Clonidine; Disease Models, Animal; Female; Guanabenz; Hyperlipidemias; Imidazoles; Imidazoline Receptors; Liver; Male; Metabolic Syndrome; Oxazoles; Rats; Rats, Inbred SHR; Receptors, Drug; Rilmenidine; Triglycerides | 2006 |
Efficacy and tolerability of rilmenidine compared with isradipine in hypertensive patients with features of metabolic syndrome.
Topics: Adult; Aged; Antihypertensive Agents; Blood Glucose; Blood Pressure; Double-Blind Method; Drug Tolerance; Female; Humans; Hypertension; Insulin; Isradipine; Lipids; Male; Metabolic Syndrome; Middle Aged; Oxazoles; Rilmenidine | 2006 |